Senate Bill 2003
115th Congress(2017-2018)
FDA Cosmetic Safety and Modernization Act
Introduced
Introduced in Senate on Oct 25, 2017
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2003
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
FDA Cosmetic Safety and Modernization Act
This bill establishes a series of requirements relating to cosmetics regulation, including requiring cosmetics manufacturers and distributors to report serious adverse health events to the Food and Drug Administration.
October 25, 2017
10/25/2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
10/25/2017
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:38:14 PM